Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Purity | ≥95% |
|---|---|
| Formula | C18H25N5O5S |
| Formula Wt. | 423.4 |
| Synonym | MGP-pNa |
| Solubility | Soluble in water. |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
Bactericidal
Mycotoxin produced by Fusarium; sphingosine acy...
Specific inhibitor of histone methyltransferase...
JAK2 inhibitor.
Quinolone alkaloid precursor of irinotecan, ori...
Synthetic catechol; ER agonist, microtubule pol...
Sulfonylurea; SUR1 antagonist.
Proteasome antigen.
Endogenous peptide, cleavage product of angiote...
Indoline; PDGFR, VEGFR, c-KIT, FLT3, mTORC1 inh...
Endogenous neuropeptide hormone; somatostatin a...
FIASMA, σ1, RyR2, TrkA/B agonist; SERT, NET in...
EZH2 inhibitor
CDK2 inhibitor.
Trihydroxybenzoic acid glycoside found in Berge...
Neuropeptide found in crustaceans and insects.<...
5-HT3 antagonist.
NSAID; COX-1/2 inhibitor.
COMT inhibitor.
TxA2 antagonist.